NephrosNEPH
13F holders, Q1 2024 (March 31)18holders
1famous investor
$2.20avg. 13F price*
At the end of Q1 2024, 18 institutions reported holding Nephros Inc. (NEPH) in their 13F filings. The largest holders were Wexford Capital LP ($7.9M), Bard Associates Inc. ($393K) and Vanguard Group Inc. ($385K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Nephros Inc.
- CUSIP
- 640671400
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $116K |
| Exits | 3 | $55K |
Ownership 18 holders
| Wexford Capital LP | 1.62% | Reduce -2.2% | 3,600,552 | $7.9M |
| Bard Associates Inc. | 0.14% | Reduce -4.2% | 179,376 | $393K |
| Vanguard Group Inc. | 0.00% | Add +2.5% | 175,649 | $385K |
| Geode Capital Management, LLC | 0.00% | No change | 71,037 | $156K |
| HighTower Advisors, LLC | 0.00% | Add +2.6% | 58,210 | $127K |
| Renaissance Technologies | 0.00% | New | 41,200 | $90K |
| Blair William & Co. | 0.00% | No change | 36,249 | $79K |
| Elkhorn Partners Limited Partnership | 0.06% | Add +12.8% | 36,000 | $79K |
| State Street Corp. | 0.00% | No change | 15,698 | $34K |
| Mesirow Financial Investment Management, Inc. | 0.00% | No change | 15,383 | $34K |
| Granite Investment Partners, LLC | 0.00% | Add +16.3% | 13,047 | $29K |
| Two Sigma Securities, LLC | 0.00% | New | 11,617 | $25K |
| Morgan Stanley | 0.00% | Reduce -83.9% | 5,423 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +76.5% | 4,401 | $10K |
| UBS Group AG | 0.00% | Add +2690.9% | 307 | $672 |
| JPMorgan Chase & Co. | 0.00% | Add +2110.0% | 221 | $484 |
| Wells Fargo & Company | 0.00% | Add +1.4% | 73 | $160 |
| NewEdge Advisors, LLC | 0.00% | New | 36 | $78 |
"% of holder's portfolio" is NEPH's weight in each manager's 13F, not the share of Nephros Inc. the manager owns.